Fintel reports that on August 7, 2023, JP Morgan maintained coverage of Myriad Genetics (NASDAQ:MYGN) with a Underweight recommendation. As of August 2, 2023, the average one-year price target for ...
RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (IRD) (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...
JScreen, a genetic testing company, partnered with country music icon Morgan Wade to spotlight the significance of gene and mutation testing. Country music sensation Morgan Wade, known for her ...
Fintel reports that on September 19, 2024, Morgan Stanley initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Equal-Weight recommendation. As of August 26, 2024, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results